Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism

被引:57
作者
Silberberg, M [1 ]
Morand, C [1 ]
Manach, C [1 ]
Scalbert, A [1 ]
Remesy, C [1 ]
机构
[1] INRA, Ctr Rech Clermont Ferrant Theix, Lab Malad Metab & Micronutriments, F-63122 St Genes Champanelle, France
关键词
rats; quercetin; catechin; co-administration; bioavailability;
D O I
10.1016/j.lfs.2005.03.033
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Quercetin and catechin are among the major flavonoids in plant foods and their intake has been associated to a risk reduction in several degenerative diseases. The aim of the present study was to bring data on the bioavailability of quercetin and catechin when administered simultaneously. The study was performed on rats adapted to diets containing (i) 0.25% quercetin, or (ii) 0.25% catechin, or (iii) 0.25% quercetin + 0.25% catechin. Quercetin, catechin and their metabolites were determined in plasma, urine and liver by HPLC with UV or coulometric detection. When quercetin and catechin were fed in association, their respective plasma concentration significantly decreased (-35% and -28% respectively), whereas the urinary and hepatic concentrations were only affected for quercetin (-36%). These data may be explained by a competitive interaction between quercetin and catechin at the digestive level, leading to a reduction of the intestinal absorption of quercetin and a possible delaying of catechin absorption over time. The simultaneous administration of quercetin and catechin had no effect on the formation of their glucurono and sulfo conjugates, indicating the absence of competition between quercetin and catechin for the corresponding conjugative enzymes. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:3156 / 3167
页数:12
相关论文
共 34 条
[1]   The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides [J].
Arts, ICW ;
Sesink, ALA ;
Faassen-Peters, M ;
Hollman, PCH .
BRITISH JOURNAL OF NUTRITION, 2004, 91 (06) :841-847
[2]   Catechin intake and associated dietary and lifestyle factors in a representative sample of Dutch men and women [J].
Arts, ICW ;
Hollman, PCH ;
Feskens, EJM ;
de Mesquita, HBB ;
Kromhout, D .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2001, 55 (02) :76-81
[3]   In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats [J].
Baba, S ;
Osakabe, N ;
Natsume, M ;
Muto, Y ;
Takizawa, T ;
Terao, J .
JOURNAL OF NUTRITION, 2001, 131 (11) :2885-2891
[4]   Anti-invasive effects of green tea polyphenol EpiGalloCatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases [J].
Benelli, R ;
Venè, R ;
Bisacchi, D ;
Garbisa, S ;
Albini, A .
BIOLOGICAL CHEMISTRY, 2002, 383 (01) :101-105
[5]   Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen [J].
Crespy, V ;
Morand, C ;
Manach, C ;
Besson, C ;
Demigne, C ;
Remesy, C .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 277 (01) :G120-G126
[6]   The splanchnic metabolism of flavonoids highly differed according to the nature of the compound [J].
Crespy, V ;
Morand, C ;
Besson, C ;
Cotelle, N ;
Vézin, H ;
Demigné, C ;
Rémésy, C .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 284 (06) :G980-G988
[7]   Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells [J].
Deprez, S ;
Mila, I ;
Huneau, JF ;
Tome, D ;
Scalbert, A .
ANTIOXIDANTS & REDOX SIGNALING, 2001, 3 (06) :957-967
[8]   Catechin is metabolized by both the small intestine and liver of rats [J].
Donovan, JL ;
Crespy, V ;
Manach, C ;
Morand, C ;
Besson, C ;
Scalbert, A ;
Rémésy, C .
JOURNAL OF NUTRITION, 2001, 131 (06) :1753-1757
[9]   Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine [J].
Dresser, GK ;
Bailey, DG ;
Leake, BF ;
Schwarz, UI ;
Dawson, PA ;
Freeman, DJ ;
Kim, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) :11-20
[10]  
DUFOUR C, 2005, BIOCHIM BIOPHYS ACTA, V1721, P165